MTE #7 Approaching Challenges in the Prediction and Treatment of Intrahepatic Cholestasis of Pregnancy 

Nov 08 2025
Convention Center: Room 156, Level 1
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Tatyana Kushner, MD, MSCE
Discussion Leader

Tatyana Kushner, MD, MSCE
CW
Discussion Leader

Catherine Williamson

Description

Experts review updates in the field for the prognostication and management of intrahepatic cholestasis of pregnancy (ICP). Speakers lead a case-based discussion about challenging ICP cases and share approaches to management from ursodiol to ileal bile acid transporter (IBAT) inhibitor treatment. Topics include the association of chronic liver disease—including primary biliary cholangitis, hepatitis C, autoimmune liver disease, and cirrhosis—with the development of ICP, and the relevance of genetic testing for individuals with ICP.

 

Journey Maps

Objectives

  • Explain how to diagnose and risk stratify individuals with intrahepatic cholestasis of pregnancy (ICP).
  • Review how to monitor patients with ICP based on AASLD and the European Association for the Study of the liver (EASL) guidance.
  • Describe novel management approaches for refractory ICP.
  • Summarize the influence of genetics and chronic liver disease on ICP development and outcomes.